International Peptide Society

What International Peptide Society does

The International Peptide Society is a private professional membership organization headquartered in Boca Raton, Florida, that advances peptide science education and research, primarily serving medical professionals, peptide researchers, and practitioners working in anti-aging and longevity medicine. Founded in 2013 (per company history and copyright 2013-2026), the society operates with a headcount of 11-50 and functions as a horizontal community serving a single persona segment: professionals and enthusiasts seeking structured peptide-related education and research collaboration.

The society's core offerings are content- and community-based rather than technology-based. Its product set consists of four core lines: structured educational content and programming on peptide science and longevity medicine, research initiatives supporting the advancement of peptide science, published monographs distributed to members on peptide-related topics, and member-focused community programming providing networking and professional development. There is no disclosed software platform, application, API, or technology stack; the society's deliverable surface is educational publishing and member services rather than software or data products. No patents, certifications, or technology integrations are recorded.

The business model is a professional membership society with no publicly disclosed pricing, membership tiers, or revenue mechanics. No revenue figures, funding rounds, or investor backing are present in the source data. The organization is undergoing a significant structural transition: in March 2026 it announced that all programs, educational resources, research initiatives, monographs, and member-focused programming are moving to the American Academy of Anti-Aging Medicine (A4M), under which the society's content and community will continue. The legal relationship with A4M (merger, acquisition, or affiliation) is not fully detailed in available materials. No management team, board composition, or ownership details are disclosed.

Name

International Peptide Society

Legal name

The International Peptide Society

Website

https://peptidesociety.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

The International Peptide Society is a private professional membership organization providing peptide science education, research initiatives, monographs, and community programming for medical professionals and longevity medicine researchers, currently transitioning its programs to A4M.

Ownership category

akta.pro rank

Product category

Professional Medical Education

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

akta.pro primary industry

Health, Wellness & Healthy Aging Education (Chronic disease, mobility, nutrition) (EDAAAMAG)

akta.pro secondary industry

Online & Hybrid Senior Learning Platforms (EDAAAMAD)

Keywords

• Peptide science education
• Longevity medicine training
• Medical professional membership
• Clinical research monographs
• Anti-aging education

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

The International Peptide Society is a private professional membership organization that advances peptide science for clinical and longevity applications. It delivers educational content, research initiatives, published monographs, and member-focused programming for medical professionals and peptide researchers. Programs, educational resources, and community initiatives are transitioning to the American Academy of Anti-Aging Medicine (A4M) umbrella.

Product overview

The International Peptide Society is a professional membership organization providing a unified platform of educational resources, research initiatives, monographs, and member-focused programming in peptide science and longevity medicine. The society's offerings are transitioning to the American Academy of Anti-Aging Medicine (A4M) platform, maintaining the same high standards for advancing peptide education. The core products consist of educational content, research programs, published monographs, and community programming that work together to serve the peptide science professional community.

Differentiator

Problem solved

Functional benefit

Products and services

• Educational Content and Programming Educational resources and structured programming focused on peptide science and longevity medicine, designed for medical professionals and researchers.
• Research Initiatives Research programs and initiatives supporting the advancement of peptide science within longevity medicine, available to society members and the research community.
• Monographs Published educational monographs covering peptide-related clinical and scientific topics, distributed to society members.
• Member-Focused Programming Community initiatives and member services providing networking and professional development opportunities for professionals engaged in peptide science.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• A4M (American Academy of Anti-Aging Medicine)coreStrategic or Co-development Partner · 1 March 2026The Peptide Society is transitioning its programs, educational resources, and community initiatives to A4M. All educational content, research initiatives, monographs, and member-focused programming will continue under the A4M umbrella, maintaining the same high standards and commitment to advancing peptide education. This represents an integration of peptide science within a broader longevity medicine platform.

Recent moves3 records

Expansion highlights3 records

Emerging players

• Thorne HealthTech: A supplements and health-products company with peptide-related product offerings in the longevity and wellness category. Comparable as an emerging commercial player in the consumer peptide/longevity space that IPS's clinical audience may interact with.
• Peptide Sciences Inc. A commercial supplier of research-grade peptides for laboratory and clinical research. Comparable as a smaller, peptide-focused operator in the research supply market that IPS members would engage with, though with a different commercial model.
• PeptiDream Inc. A Japanese biopharma company specializing in peptide discovery and development using its proprietary Peptide Discovery Platform System. Comparable as a peptide-specialized organization at the intersection of research and clinical application, though driven by a commercial drug-development model rather than membership education.

Direct peers

• American Peptide Society: A professional scientific society dedicated to advancing peptide research in the United States. It is the most direct comparitor to IPS, serving an overlapping community of peptide scientists and clinicians, with a similar membership-society and educational-meeting model.

Regional players

• European Peptide Society: The European counterpart scientific society for peptide science, organizing the European Peptide Symposium and serving researchers across Europe. Directly comparable as a peptide-focused professional society, but geographically regional relative to IPS's US base.
• Japanese Peptide Society: Japan's national professional society for peptide science. Directly comparable in mission and structure to IPS, but serves the Japanese research community rather than competing in IPS's markets.

Broad incumbents

• Lonza Group AG: A major global CDMO with peptide manufacturing capabilities. Comparable as a large-scale commercial player in the peptide value chain that IPS members interface with, though operating with a fundamentally different manufacturing-driven business model.
• Bachem Holding AG: A leading global CDMO specializing in peptide and oligonucleotide manufacturing. Operates in the broader peptide ecosystem IPS educates about, supplying APIs for peptide therapeutics; relevant as a commercial incumbent connecting peptide science to clinical use.
• A4M (American Academy of Anti-Aging Medicine): A4M is the dominant professional society for anti-aging and longevity medicine, and is now the transitional parent platform for IPS's programs. Comparable as a longevity-medicine membership and education organization, but operates at much broader scale across all anti-aging modalities, not just peptides.

Others

• International Peptide Symposium: A recurring international scientific conference on peptide research. Thematically aligned with IPS's peptide science mission and overlapping attendee base, but operates as a periodic scientific event rather than an ongoing membership society.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks1 record

Customer concentration

• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Peptide Society